Get started
Author

Justine Pasteur

Observed name: J. Pasteur
ORCID: 0000-0002-4766-0693
Observed ORCID: 0000-0002-4766-0693
OpenAlex ID: A5032487737
Reverse Phenotyping in Patients with Skin Capillary Malformations and Mosaic GNAQ or GNA11 Mutations Defines a Clinical Spectrum with Genotype-Phenotype Correlation
2019 · Maud Jordan, Virginie Carmignac, et al. · Journal of Investigative Dermatology · 47
PDF
Low Cross-Reactivity Between Cisplatin and Other Platinum Salts
2019 · Justine Pasteur, Laure Favier, et al. · The Journal of Allergy and Clinical Immunology In Practice · 37
PDF
Inhibition of the Receptor for Advanced Glycation End-Products in Acute Respiratory Distress Syndrome: A Randomised Laboratory Trial in Piglets
2018 · Jules Audard, Thomas Godet, et al. · Scientific Reports · 37
PDF
Multiple cases of sensitization to an antiseptic containing chlorhexidine digluconate/benzalkonium chloride/benzyl alcohol with different profiles of sensitization in adults and children
2022 · Charlotte Beaumont, Anne‐Sophie Darrigade, et al. · Contact Dermatitis · 25
Impact of dupilumab on patch test results and allergic contact dermatitis: A prospective multicenter study
2023 · Sarah Bocquel, Angèle Soria, et al. · Journal of the American Academy of Dermatology · 18
Effectiveness and tolerance of Janus kinase inhibitors for the treatment of recalcitrant atopic dermatitis in a real-life French multicenter adult cohort
2022 · Julia Vanlerberghe, Frédéric Dezoteux, et al. · Journal of the American Academy of Dermatology · 18
PDF
What is the optimal duration for a ROAT ? The experience of the French Dermatology and Allergology group ( DAG )
2022 · Emmanuelle Amsler, Haudrey Assier, et al. · Contact Dermatitis · 18
Hand eczema in glove‐wearing patients
2023 · Aude Clément, Marie‐Christine Ferrier le Bouëdec, et al. · Contact Dermatitis · 15
PDF
Switching From Dupilumab to Tralokinumab or Janus Kinase Inhibitors in Cases of Ocular and/or Facial Adverse Events in Patients With Atopic Dermatitis: A Multicenter Retrospective Study
2024 · Alexandre Beyrouti, Juliette Deuze, et al. · The Journal of Allergy and Clinical Immunology In Practice · 13
First Two Cases of Allergic Contact Dermatitis From Isobutylamido Thiazolyl Resorcinol (‘Thiamidol’) in Depigmenting Skin Care Routine
2025 · Léopoldine Vernhet, Ella Dendooven, et al. · Contact Dermatitis · 8
Glove‐related contact dermatitis: Diagnostic value of a repeated application test
2024 · Céline Lamouroux, Léa Bertolotti, et al. · Contact Dermatitis · 6
PDF
Efficacy and tolerance of dupilumab in patients with moderate‐to‐severe atopic dermatitis and obesity
2024 · Joséphine Dupuis, Marie Tauber, et al. · Journal of the European Academy of Dermatology and Venereology · 5
Topical versus oral corticosteroids in moderate drug reaction with eosinophilia and systemic symptoms: A multicenter randomized clinical trial
2024 · Saskia Ingen-Housz-Oro, Elie Guichard, et al. · Journal of the American Academy of Dermatology · 5
PDF
Sensitizations to all nonionic iodinated contrast media: A particular presentation after delayed hypersensitivity reactions
2025 · Angèle Soria, Evelyne Collet, et al. · The Journal of Allergy and Clinical Immunology In Practice · 1
Management of Tinea Capitis in children under 10 kg : Results from a French multicentre study
2025 · A. Cornillault, S. Ranque, et al. · Journal of the European Academy of Dermatology and Venereology · 1
PDF
Durée optimale du ROAT, expérience du groupe dermato allergologie de la Société française de dermatologie
2021 · Emmanuelle Amsler, Haudrey Assier, et al. · Annales de Dermatologie et de Vénéréologie - FMC · 1
Dermatite périoculaire au cours du traitement d’une DMLA : polysensibilisation à l’EYLEA® (aflibercept) et aux collyres tétracaïne et azythromycine
2019 · M. Jordan, A. Prost, et al. · Annales de Dermatologie et de Vénéréologie · 1
Correction: Effectiveness and Safety of IL‑17A Inhibitors in Pediatric Psoriasis: A Real‑World, Multicenter, International Study
2026 · Vito Di Lernia, Bertille Bonniaud, et al. · Pediatric Drugs
PDF
Peripheral vasomotor symptoms: Expanding the phenotype of GNA11 ‐related capillary malformations
2026 · O. Boccara, C. Labrèze, et al. · Journal of the European Academy of Dermatology and Venereology
PDF
Effectiveness and Safety of IL-17A Inhibitors in Pediatric Psoriasis: A Real-World, Multicenter, International Study
2026 · Vito Di Lernia, Bertille Bonniaud, et al. · Pediatric Drugs
Efficacy of dupilumab in atopic dermatitis with prurigo: a real-life study
2026 · Amandine Beaune, Aude Clément, et al. · Clinical and Experimental Dermatology
Real-World Systemic Treatment Patterns and Outcomes of Children With Severe Alopecia Areata: A French Nationwide Study (ESTAPED Cohort)
2026 · Ninon Le Goaziou, Christine Bodemer, et al. · Pediatric Drugs
PDF
Intérêt du test d’application répétée au gant en médecine du travail pour le diagnostic précoce d’allergie de contact aux gants
2026 · Léa Bertolotti Potachin, Céline Lamouroux, et al. · Archives des maladies professionnelles et de médecine du travail/Archives des maladies professionnelles et de l'environnement
Linear and whorled hypermelanosis: A multicentre retrospective cohort of 33 patients
2026 · Marion Descos, Paul Kuentz, et al. · Journal of the European Academy of Dermatology and Venereology
Étude observationnelle multicentrique française prospective de survenue d’effets indésirables ophtalmologiques chez les patients traités par tralokinumab pour une dermatite atopique. Étude TRALO ŒIL – analyse intermédiaire
2025 · R. Viel, C. Renaudin, et al. · Annales de Dermatologie et de Vénéréologie - FMC
Works count: 48
Citation count: 256
H-index: 9
I10-index: 9
Year
Topic
Type